Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 32, 2024 - Issue 5
Submit an article Journal homepage
71
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Vitreous Haemorrhage and Retinal Neovascularization Secondary to Peripheral Retinal Ischemia as the Presenting Sign of a Disseminated Melanoma

Peter Kiralya Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United KingdomORCID Iconhttps://orcid.org/0000-0002-7980-4401View further author information
, MDORCID Icon,
Samantha R. De Silvaa Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;b Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United KingdomView further author information
, MA, MRCP, FRCOphth, DPhil &
Niamh Stonea Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United KingdomCorrespondence[email protected]
View further author information
, BSc, MBChB, MRCP, FRCOphth
Pages 703-706 | Received 03 Jan 2023, Accepted 28 Mar 2023, Published online: 18 Apr 2023

References

  • Elsheikh S, Gurney SP, Burdon MA. Melanoma-associated retinopathy. Clin Exp Dermatol. 2020;45(2):147–152. doi:10.1111/ced.14095.
  • Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian J Ophthalmol. 2020;68(9):1829–1837. doi:10.4103/ijo.IJO_786_20.
  • Lu Y, Jia L, He S, et al. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol (Chicago, Ill: 1960). 2009;127(12):1572–1580. doi:10.1001/archophthalmol.2009.311.
  • Potter MJ, Thirkill CE, Dam OM, Lee AS, Milam AH. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106(11):2121–2125. doi:10.1016/S0161-6420(99)90493-1.
  • Forooghian F, Cao S, Cui J, Matsubara JA. The enigma of autoimmune retinopathy. Int Ophthalmol Clin. 2015;55(2):81–91. doi:10.1097/IIO.0000000000000063.
  • Powell SF, Dudek AZ. Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol. 2010;12(1):54–63. doi:10.1007/s11940-009-0057-x.
  • Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol. 2008;28(1):5–11. doi:10.1097/WNO.0b013e318167549f.
  • Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Documenta Ophthalmologica Adv Ophthalmol. 2011;123(1):59–63. doi:10.1007/s10633-011-9277-y.
  • Kim SJ, Toma HS, Thirkill CE, Dunn JP Jr. Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflammation. 2010;18(2):107–109. doi:10.3109/09273940903457441.
  • Ohnishi Y, Ohara S, Sakamoto T, Kohno T, Nakao F. Cancer-associated retinopathy with retinal phlebitis. British J Ophthalmol. 1993;77(12):795–798. doi:10.1136/bjo.77.12.795.
  • Ksiaa I, Kechida M, Zina S, Lahdhiri M, Abroug N, Khairallah M. Acute lymphoblastic leukemia relapse presenting as retinal vasculitis. Clin Case Rep. 2020;8(8):1467–1471. doi:10.1002/ccr3.2895.
  • Sonne SJ, Shieh WS, Srivastava SK, Smith BT. Lymphoma masquerading as occlusive retinal vasculitis: a case study. Am J Ophthalmol Case Rep. 2020;19:100777. doi:10.1016/j.ajoc.2020.100777.
  • Primka EJ 3rd, King C, O’Keefe EJ. Malignant melanoma of unknown origin presenting as a systemic vasculitis. Arch Dermatol. 1993;129(9):1205–1207. doi:10.1001/archderm.129.9.1205b.
  • Remulla JF, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol (Chicago, Ill: 1960). 1995;113(7):854–855. doi:10.1001/archopht.1995.01100070024015.
  • Fortes BH, Liou H, Dalvin LA. Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience. Br J Ophthalmol. 2021;105(9):1263–1271. doi:10.1136/bjophthalmol-2020-316970.
  • Méndez-Martínez S, Calvo P, Ruiz-Moreno O, et al. Ocular adverse events associated with mek inhibitors. Retina. 2019;39(8):1435–1450. doi:10.1097/IAE.0000000000002451.
  • Cao R, Cao Y. Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling. Cell Cycle. 2010;9(10):1882–1885. doi:10.4161/cc.9.10.11521.
  • Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia (New York, NY). 2002;4(6):465–473. doi:10.1038/sj.neo.7900263.
  • Sparsa A, Durox H, Doffoel-Hantz V, et al. High prevalence and risk factors of thromboembolism in stage IV melanoma. J Eur Acad Dermatol Venereol. 2011;25(3):340–344. doi:10.1111/j.1468-3083.2010.03795.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.